Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | Original Paper

Developmental regulation of the expression of the transferrin receptor and Ki67 in oocytes of the baboon fetal ovary by estrogen

Authors: Marcia G. Burch, Chunhua Li, Eugene D. Albrecht, Gerald J. Pepe

Published in: Endocrine | Issue 2/2009

Login to get access

Abstract

We previously showed that estrogen regulates baboon fetal ovarian follicle development and oocyte integrity. Because iron incorporated into cells by the transferrin receptor is essential for cell/nuclear function, we determined whether fetal oocyte expression of transferrin receptor and the nuclear protein Ki67 were developmentally regulated by estrogen and associated with DNA integrity/fragmentation. Transferrin-receptor expression was minimal at midgestation and abundant in late gestation and localized to the cytoplasm and surface of oocytes of primordial follicles. Expression of transferrin receptor, however, was negligible in oocytes in fetuses in which serum estradiol-17β levels were suppressed (>95%) by daily maternal treatment between mid- and late gestation with the aromatase inhibitor letrozole and partially restored by treatment with letrozole and estradiol benzoate. Ki67 was localized to pregranulosa and germ cells at midgestation and throughout the oocyte nucleus in late gestation in estrogen-replete fetuses. In contrast, in estrogen-suppressed fetuses, Ki67 was localized to a limited number of foci around the oocyte nucleus. Apoptosis detected in pregranulosa and germ cells at midgestation was not observed in late gestation in estrogen-replete/-suppressed fetuses. We conclude that estrogen regulates fetal oocyte transferrin-receptor expression and that inhibition of receptor development is associated with alterations in Ki67 expression by the oocyte but not apoptosis. Collectively, these results and our previous studies further define the essential role of estrogen in regulating development of follicles comprised of healthy oocytes by the baboon fetal ovary.
Literature
10.
go back to reference G.C. Balboni, G.B. Vannelli, T. Barni, C. Orlando, M. Serio, Fertil. Steril. 48, 796–801 (1987)PubMed G.C. Balboni, G.B. Vannelli, T. Barni, C. Orlando, M. Serio, Fertil. Steril. 48, 796–801 (1987)PubMed
11.
12.
go back to reference A.E. Baltus, D.B. Menke, Y.C. Hu, M.L. Goodheart, A.E. Carpenter, D.G. de Rooij, D.C. Page, Nat. Genet. 38, 1430–1434 (2006)CrossRefPubMed A.E. Baltus, D.B. Menke, Y.C. Hu, M.L. Goodheart, A.E. Carpenter, D.G. de Rooij, D.C. Page, Nat. Genet. 38, 1430–1434 (2006)CrossRefPubMed
18.
go back to reference H. Stoop, F. Honecker, M. Cools, R. de Krijger, C. Bokemeyer, L.H. Looijenga, Hum. Reprod. 20, 1466–1476 (2005)CrossRefPubMed H. Stoop, F. Honecker, M. Cools, R. de Krijger, C. Bokemeyer, L.H. Looijenga, Hum. Reprod. 20, 1466–1476 (2005)CrossRefPubMed
19.
go back to reference Y. Liu, C. Wu, Q. Lyu, D. Yang, D.F. Albertini, D.L. Keefe, L. Liu, Dev. Biol. 306, 112–120 (2007)CrossRefPubMed Y. Liu, C. Wu, Q. Lyu, D. Yang, D.F. Albertini, D.L. Keefe, L. Liu, Dev. Biol. 306, 112–120 (2007)CrossRefPubMed
21.
go back to reference G.J. Pepe, R.B. Billiar, M.G. Leavitt, N.C. Zachos, J.A. Gustafsson, E.D. Albrecht, Biol. Reprod. 66, 1054–1060 (2002)CrossRefPubMed G.J. Pepe, R.B. Billiar, M.G. Leavitt, N.C. Zachos, J.A. Gustafsson, E.D. Albrecht, Biol. Reprod. 66, 1054–1060 (2002)CrossRefPubMed
23.
go back to reference A. Ciechanover, A.L. Schwartz, A. Dautry-Varsat, H.F. Lodish, J. Biol. Chem. 258, 9681–9689 (1983)PubMed A. Ciechanover, A.L. Schwartz, A. Dautry-Varsat, H.F. Lodish, J. Biol. Chem. 258, 9681–9689 (1983)PubMed
24.
go back to reference R.D. Klausner, J. van Renswoude, G. Ashwell, C. Kempf, A.N. Schechter, A. Dean, K.R. Bridges, J. Biol. Chem. 258, 4715–4724 (1983)PubMed R.D. Klausner, J. van Renswoude, G. Ashwell, C. Kempf, A.N. Schechter, A. Dean, K.R. Bridges, J. Biol. Chem. 258, 4715–4724 (1983)PubMed
25.
go back to reference K.C. Gatter, G. Brown, I.S. Trowbridge, R.E. Woolston, D.Y. Mason, J. Clin. Pathol. 36, 539–545 (1983)CrossRefPubMed K.C. Gatter, G. Brown, I.S. Trowbridge, R.E. Woolston, D.Y. Mason, J. Clin. Pathol. 36, 539–545 (1983)CrossRefPubMed
26.
go back to reference S.S. Entman, W.S. Maxson, C.A. Bradley, K. Osteen, B.W. Webster, W.K. Vaughn, A.C. Wentz, J. In Vitro Fertil. Embryo Transf. 4, 98–102 (1987)CrossRef S.S. Entman, W.S. Maxson, C.A. Bradley, K. Osteen, B.W. Webster, W.K. Vaughn, A.C. Wentz, J. In Vitro Fertil. Embryo Transf. 4, 98–102 (1987)CrossRef
27.
go back to reference T. Mantzavinos, N. Dalamanga, D. Hassiakos, F. Dimitriadou, O. Gregoriou, P.A. Zourlas, Clin. Exp. Obstet. Gynecol. 20, 32–36 (1993)PubMed T. Mantzavinos, N. Dalamanga, D. Hassiakos, F. Dimitriadou, O. Gregoriou, P.A. Zourlas, Clin. Exp. Obstet. Gynecol. 20, 32–36 (1993)PubMed
29.
go back to reference S.M. Bocca, R.B. Billiar, E.D. Albrecht, G.J. Pepe, Endocrine, Published May 17, 2008; PMID: 18484193 (2008) S.M. Bocca, R.B. Billiar, E.D. Albrecht, G.J. Pepe, Endocrine, Published May 17, 2008; PMID: 18484193 (2008)
30.
Metadata
Title
Developmental regulation of the expression of the transferrin receptor and Ki67 in oocytes of the baboon fetal ovary by estrogen
Authors
Marcia G. Burch
Chunhua Li
Eugene D. Albrecht
Gerald J. Pepe
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9133-3

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.